Le Lézard
Classified in: Health, Science and technology, Business
Subjects: ECO, CFG

Canadian farmers, entrepreneurs and health care workers to benefit from new investment in research


More than $20 million for collaborations between researchers and businesses to save lives, help farmers and protect the environment

LINCOLN, ON, Aug. 16, 2018 /CNW/ - Putting research in the hands of those who use it to create and innovate leads to increased competitiveness, economic growth and job creation. That's why the Government of Canada continues to support the country's researchers whose discoveries inspire entrepreneurs and innovators in the agriculture, health and commercial sectors.

Today,  the Honourable Kirsty Duncan, Minister of Science and Sport, announced $6.7 million in federal funding for seven new projects under Genome Canada's Genomic Applications Partnership Program (GAPP) that will match researchers with companies to develop new gene-based technologies in health care, agriculture and  environmental protection. An additional $14.3 million is being invested by provincial governments, businesses and other funding partners for a total of $21 million.  

By studying genetic sequences, researchers develop technologies or processes that will improve crop growth, find a better treatment for babies born with a rare disease called cystinosis, and better protect wildlife, among other innovations.  Genomics involves the study of genes, other DNA sequences and associated biological information that makes every organism different.

Minister Duncan made the announcement at Vineland Research and Innovation Centre, one of the seven research institutions receiving GAPP funding. This world-class centre for horticulture science and innovation will partner with a team of University of Toronto researchers to create new varieties of vegetables that will be more resistant to diseases.  Resilient vegetables will help increase how much Canadian farmers can grow during a season, giving them a competitive advantage in the billion-dollar agricultural industry.

This is one example of how science leads to new opportunities and good quality jobs. Today's investment in these projects will help businesses grow while supporting a stronger middle class.

Quotes

"It all starts with science and our remarkable scientists. By investing in researchers, we are giving them the opportunity to work with each other and their counterparts in the business, health and agriculture sectors to find the ideas and innovations that power a stronger economy and a growing middle class. Congratulations to our successful recipients whose efforts will help us build a bolder, brighter future for all Canadians.
? Honourable Kirsty Duncan, Minister of Science and Sport

"These projects are a great illustration of how genomics impacts Canadians. From improving therapies for rare diseases in humans, to protecting caribou populations, to enhancing disease resistance in vegetables and crops, genomic tools and solutions are everywhere."  
? Mr. Marc LePage, President and CEO, Genome Canada

"Today's announcement reflects the shared commitment Mitacs and Genome Canada have in supporting up-and-coming researchers whose groundbreaking work in genomics will have significant, multi-sector impacts on our country's economic well-being."
? Dr. Ridha Ben Mrad, Chief Research Officer, Mitacs

Quick facts

Related Links
GAPP Round 9 ? Backgrounder list of projects funded

Twitter: @CDNScience; @ISED_CA; @GenomeCanada

Genome Canada is a not-for-profit organization that invests in genomic science and technology and its translation into applications across multiple sectors to produce social and economic benefits for Canadians.

Mitacs is a national, not-for-profit organization that has designed and delivered research and training programs in Canada for 19 years. Working with more than 60 universities, thousands of companies, and both federal and provincial governments, Mitacs builds partnerships that support industrial and social innovation in Canada.

 

SOURCE Genome Canada


These press releases may also interest you

at 16:00
PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") , a specialty pharmaceutical company, today announced receipt of a Complete Response Letter ("CRL") for its Priority Original Abbreviated New Drug Application ("ANDA") for Ketamine that was...

at 15:44
ProSource360 announces it has been chosen to participate in Pfizer's Diverse OnDemand pilot program, a procurement-developed self-serve tool designed to simplify the diverse supplier contracting process. ProSource360 is one of only 11 suppliers who...

at 15:32
Hyde Park Capital announced today that its client, Accuhealth Technologies ("Accuhealth"), a leading healthcare technology company with a focus on remote patient monitoring and chronic care management solutions, has received a growth investment...

at 15:30
Bayer is recalling two lots of hydraSense® Baby Nasal Care Easydose® due to a potential contamination. Lots containing the following...

at 15:30
Mark T. Elliot has joined Crowell & Moring International LLC (CMI) as senior director, bringing more than three decades of experience providing strategic public affairs, communications, government affairs and trade policy advice across a range of...

at 15:30
United Breast Cancer Foundation (UBCF) is calling on volunteers and the Warwick, Rhode Island community to join us for a day dedicated to those battling breast cancer! The "Gifts of Comfort and Hope" Mattress & Pink Bag Event on Saturday, April 27th...



News published on and distributed by: